Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barré syndrome

ABSTRACT

The purpose of this study was to investigate the prognostic value of the pretreatment and post-treatment albumin level, neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) in subtypes of Guillain-Barré syndrome (GBS). A retrospective analysis of 62 patients with GBS treated between 2011 and 2015 in Dicle University Hospital, Turkey, was carried out. The pretreatment and post-treatment albumin, NLR, and PLR were documented, together with acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy, motor sensory axonal neuropathy, and Hughes’ scores. Post-treatment albumin levels in GBS were significantly reduced, and albumin level was negatively correlated with the Hughes scores. Elevated pretreatment NLRs and PLRs were significantly associated with AIDP. There were no correlations between the Hughes scores, NLR, and PLR. The results point to a negative correlation between albumin levels and GBS disability and suggest that the NLR and PLR may be promising blood biomarkers of AIDP.

RESUMO

O objetivo deste estudo foi investigar o valor prognóstico dos níveis pré e pós-tratamento de albumina , da relação neutrófilo/linfócito (RNL) e da relação plaqueta/linfócito (RPL) em subtipos de síndrome de Guillain-Barré (SGB). Realizou-se uma análise retrospectiva de 62 pacientes com GBS, tratados entre 2011 e 2015 no Hospital da Universidade Dicle, na Turquia. Os valores pré e pós-tratamento de albumina, RNL e RPL foram documentados, juntamente com polirradiculoneuropatia desmielinizante inflamatória aguda, (PDIA) neuropatia axonal motora aguda, neuropatia axonal sensorial motora e pontuações de Hughes. Os níveis de albumina reduziram significativamente pós-tratamento e correlacionaram-se negativamente com as pontuações de Hughes. RNLs e RPLs pré-tratamento elevados foram significativamente associados à PDIA. Não houve correlação entre as pontuações de Hughes, RNL e RPL. Os resultados apontam uma correlação negativa entre os níveis de albumina e a deficiência na SGB e sugerem que a RNL e a RPL possam ser promissores biomarcadores sanguíneos para PDIA.

Guillain-Barré syndrome - albumin - neutrophil-lymphocyte ratio - platelet-lymphocute ratio

síndrome de Guillain-Barré - albumina - relação neutrófilo/linfócito - relação linfócito-plaquetas

• References

• 1 Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008;7(10):939-50. doi:10.1016/S1474-4422(08)70215-1
• 2 Varol S, Ozdemir HH, Akil E, Arslan D, Aluclu MU, Demir CF et al. Facial diplegia: etiology, clinical manifestations, and diagnostic evaluation. Arq Neuropsiquiatr. 2015;73(12):998-1001. doi:10.1590/0004-282X20150174
• 3 Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469-82. doi:10.1038/nrneurol.2014.121
• 4 Mungan S, Eruyar E, Güzel I, Bilen Ş, Ak F. Prognostic factors in Guillain-Barre syndrome. Dicle Med J. 2014;41(4):667-70. doi:10.5798/diclemedj.0921.2014.04.0496
• 5 Akıl E, Bulut A, Kaplan İ, Özdemir HH, Arslan D, Aluçlu MU. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, andneutrophil/lymphocyte ratio in Parkinson’s disease. Neurol Sci. 2015;36(3):423-8. doi:10.1007/s10072-014-1976-1
• 6 Aras YG, Gungen BD, Kotan D. Neutrophil/Lymphocyte ratio in migraine patients and ıts correlation with aura. Ajans. 2015;3(4):162-6.
• 7 Koseoglu HI, Altunkas F, Kanbay A, Doruk S, Etikan I, Demir O. Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. J Thromb Thrombolysis. 2015;39(2):179-85. doi:10.1007/s11239-014-1103-4
• 8 Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47(17):2633-41. doi:10.1016/j.ejca.2011.03.028
• 9 Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R et al. Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599-612. doi:10.1016/j.vaccine.2010.06.003
• 10 Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750-3. doi: 10.1016/S0140-6736(78)92644-2
• 11 Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998;44(5):780-8. doi:10.1002/ana.410440512
• 12 Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol. 1995;38(5):809-16. doi:10.1002/ana.410380516
• 13 Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432-7. doi:10.1111/j.0894-0959.2004.17603.x
• 14 Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc. 2004;104(8):1258-64. doi:10.1016/j.jada.2004.05.213
• 15 De Feo P, Lucidi P. Liver protein synthesis in physiology and in disease states. Curr Opin Clin Nutr Metab Care. 2002;5(1):47-50. doi:10.1097/00075197-200201000-00009
• 16 Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest. 2002;110(4):437-9. doi:10.1172/JCI0216494
• 17 Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A et al. Serum albumin: a late-reacting negative acute-phase protein in clinically evident inflammation in dialysis patients. Nephrol Dial Transplant. 2005;20(3):658-9. doi:10.1093/ndt/gfh663
• 18 Hahn AF. Guillain-Barré syndrome. Lancet. 1998;352(9128):635-41. doi:10.1016/S0140-6736(97)12308-X
• 19 Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P et al. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis. J Neuroimmunol. 2003;134(1-2):118-27. doi:10.1016/S0165-5728(02)00393-4
• 20 Berciano J, Figols J, García A, Calle E, Illa I, Lafarga M et al. Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study. Muscle Nerve. 1997;20(7):846-57. doi:10.1002/(SICI)1097-4598(199707)20:7<846::AID-MUS9>3.0.CO;2-7
• 21 McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993; 33:333. doi:10.1002/ana.410330402
• 22 Kimura J. Proximal versus distal slowing of motor nerve conduction velocity in the Guillain-Barré syndrome. Ann Neurol. 1978;3(4):344-50. doi:10.1002/ana.410030412
• 23 Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol. 2001;58(6):913-7. doi:10.1001/archneur.58.6.913
• 24 Alan S, Tuna S, Türkoğlu EB. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci. 2015;31(12):626-31. doi:10.1016/j.kjms.2015.10.010
• 25 Akıl E, Akıl MA, Varol S, Özdemir HH, Yücel Y, Arslan D et al. Echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio are novel inflammatory predictors of cerebral ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(9):2328-34. doi:10.1016/j.jstrokecerebrovasdis.2014.04.028
• 26 Kokcu A, Kurtoglu E, Celik H, Tosun M, Malatyalioglu E, Ozdemir AZ. May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer? Asian Pac J Cancer Prev. 2014;15(22):9781-4. doi:10.7314/APJCP.2014.15.22.9781